Sr. Clinical Scientist

• Support execution of clinical development strategy for Phase II and Phase III clinical programs.
• Contribute to End-of-Phase II planning, including FDA briefing documents, regulatory meeting preparation, Phase III protocol development, endpoint selection, and dose justification.
• Interpret emerging clinical efficacy, safety, PK/PD, biomarker, and exploratory endpoint data to support scientific and clinical decision-making.
• Monitor evolving scientific literature and competitive intelligence to inform clinical development strategy.

• Lead ongoing clinical data review activities throughout study execution to ensure data quality, integrity, and inspection readiness.
• Review patient-level clinical data for completeness, consistency, protocol compliance, and medical relevance.
• Analyze efficacy, safety, biomarker, laboratory, imaging, pharmacokinetic, and external vendor data to identify trends and proactively resolve issues.
• Partner with Medical Monitoring on review of serious adverse events (SAEs), safety narratives, signal detection, and benefit-risk assessments.
• Review Tables, Figures, Listings (TFLs), clinical narratives, and study reports to support data interpretation.

• Partner closely with Clinical Operations, Data Management, Biometrics, Pharmacovigilance, Regulatory Affairs, Clinical Pharmacology, Translational Medicine, Medical Writing, and Medical Affairs throughout study execution.
• Collaborate with Data Management on CRF design, edit checks, data validation plans, database builds, data review specifications, and external data integration.
• Provide clinical input into study design, endpoint definitions, data collection strategies, and User Acceptance Testing (UAT) of EDC systems and clinical technologies.
• Participate in study team meetings, safety review meetings, dose-escalation committees, and data review meetings.

• Author and review clinical development documents including protocols, Clinical Study Reports (CSRs), Investigator Brochures, regulatory submissions, abstracts, publications, and scientific presentations.
• Support inspection and audit readiness activities.
• Contribute to development of clinical data review processes, SOPs, work instructions, and best practices.
• Perform other duties as assigned.

• Advanced degree (PharmD, PhD, MS, MPH, or equivalent) in life sciences, clinical research, or related field preferred. Bachelor’s degree with significant relevant experience may be considered.
• 6+ years of experience in clinical development, clinical science, data management, or related functions within biotechnology, pharmaceutical, or CRO environments.
• Demonstrated experience performing ongoing clinical data review in late phase clinical studies
• Demonstrated experience performing ongoing clinical data review, summarization and interpreting efficacy, safety, biomarker, and PK/PD data
• Experience supporting Phase II and/or Phase III clinical trials.
• Experience working closely with Clinical Operations, Data Management and Biometrics teams.

• Immunology experience is strongly preferred.
• Strong analytical and problem-solving skills with the ability to interpret complex clinical datasets.
• Understanding of external data sources, including laboratory, imaging, biomarker, and pharmacokinetic data.
• Ability to synthesize complex clinical data into actionable insights.
• Strong scientific curiosity and attention to detail.
• Excellent communication and presentation skills.
• Proven ability to work effectively in highly cross-functional teams.
• Comfortable operating in a fast-paced, evolving biotechnology environments

Avalo Therapeutics is a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases.

Avalo is advancing its lead anti-IL-1β monoclonal antibody (mAb) drug candidate, abdakibart, into a phase 3 registrational program in hidradenitis suppurativa (HS), a chronic inflammatory skin condition that affects an estimated 1–4% of the population globally.

Avalo is pursuing additional development opportunities in IL-1β driven indications.

Avalo is also developing AVTX-010, a long-acting next-generation anti-IL-1β mAb.

For more information about Avalo, please visit www.avalotx.com .

A member of the Avalo Human Resources Department will contact an agency directly if an open position is eligible to be sourced from an outside recruiting service.

Avalo does not accept unsolicited resumes from employment agencies for any employment opportunity.

All agencies/recruiters must have a written agreement/SOW in place with Avalo and prior to submitting any resume or CV.

All resumes must be submitted through the appropriate process. Any resumes submitted without an agreement and/or any resumes sent unsolicited through e-mail accounts of Avalo employees will be considered outside of the appropriate process, do not imply or create any obligation on our part, do not impart any restrictions on Avalo with respect to the hiring of any persons whose resumes are so submitted and are not eligible for placement fees.